Johnson & Johnson, Risperdal maker hit with $8B verdict
 

A Philadelphia jury has decided that Johnson & Johnson and Janssen Pharmaceuticals should pay $8 billion over an antipsychotic drug that the plaintiff's attorneys say is linked to the growth of female breast tissue in boys

أكثر...